Plasma resilience: Europe’s lifeline — and why we must strengthen it now
When we think of medical breakthroughs, we rarely think of medicines made from human plasma. However, this golden, protein-rich liquid — accounting for 55% of our blood — is essential for the development of therapies for countless conditions, from rare inherited disorders to immunodeficiencies.
When we think of medical breakthroughs, we rarely think of medicines made from human plasma. However, this golden, protein-rich liquid — accounting for 55% of our blood — is essential for the development of therapies for countless conditions, from rare inherited disorders to immunodeficiencies.